Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nutriwound is an oral nutritional supplement developed by Centaur Pharmaceuticals (The Centaur Company) for the management and accelerated healing of diabetic foot ulcers and other non-healing wounds. It is formulated as a capsule containing a combination of multivitamins, multiminerals, and the botanical extract *Hintonia latiflora*. *Hintonia latiflora* and chromium help support healthy blood sugar levels and insulin function, while vitamins (such as Vitamin A, B complex, C, D, and E) and minerals (such as zinc and selenium) work synergistically to promote re-epithelialization, collagen synthesis, membrane repair, and antioxidant defense, thereby facilitating faster wound recovery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nutriwound.